Kristina Burow's Net Worth
$931 Thousand
Who is Kristina Burow?
Kristina Burow does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Receptos, Inc., Neumora Therapeutics, Inc., DA32 Life Science Tech Acquisition Corp., Gossamer Bio, Inc., Scholar Rock Holding Corp, Erasca, Inc., Verve Therapeutics, Inc., Vir Biotechnology, Inc., Beam Therapeutics Inc., Metacrine, Inc., Unity Biotechnology, Inc., Sienna Biopharmaceuticals, Inc., Prime Medicine, Inc., Boundless Bio, Inc., and Rapport Therapeutics, Inc..
SEC CIK
Kristina Burow's CIK is 0001569248
Past Insider Trading and Trends
2021 was Kristina Burow's most active year for acquiring shares with 11 total transactions. Kristina Burow's most active month to acquire stocks was the month of May. 2015 was Kristina Burow's most active year for disposing of shares, totalling 4 transactions. Kristina Burow's most active month to dispose stocks was the month of July. 2023 saw Kristina Burow paying a total of $0.00 for 166,943 shares, this is the most they've acquired in one year. In 2015 Kristina Burow cashed out on 53,946 shares for a total of $5,931,588.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sana Biotechnology, Inc. (SANA) Snapshot price: $5.05
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.39% | 1.82M |
$5.50 | $9,999,995.50 | 35.56M |
Feb 8
| |||
Form 4
| +14,957.26% | 43.75M |
—
|
—
| 44.04M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Erasca, Inc. (ERAS) Snapshot price: $2.86
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 11.06M |
—
|
—
| 11.06M |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Verve Therapeutics, Inc. (VERV) Snapshot price: $5.595
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.51M |
—
|
—
| 2.51M |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Prime Medicine, Inc. (PRME) Snapshot price: $3.4303
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.2M |
$6.25 | $20,000,000.00 | 3.2M |
Feb 15
| |||
Form 4
|
∞
| 12.26M |
$17.00 |
—
| 12.26M |
Oct 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Rapport Therapeutics, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.73M |
—
|
—
| 3.73M |
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |